FLINT, Mich., July 23, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. DPLO, will release its second-quarter 2018 operating results after market close Monday, Aug. 6, with a conference call to follow at 5 p.m. ET.

Shareholders and interested participants can listen to a live broadcast by calling 833.286.5805 (647.689.4450 for international callers) and entering the participation code 1842529, starting about 15 minutes before the call. A live webcast of the conference call will be available on the investor relations section of Diplomat's website at ir.diplomat.is. The site will host an audio recording and supplemental investor information for 90 days.

About Diplomat
Diplomat DPLO is the nation's largest independent provider of specialty pharmacy services—helping people with complex health conditions in all 50 states. Rooted in this patient care expertise, Diplomat also provides industry-focused specialty solutions through two brands: CastiaRx, which serves payers as the leading specialty benefit manager, and EnvoyHealth, which offers tailored solutions for healthcare innovators. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care. For more information, visit diplomat.is.

INVESTOR CONTACT:
Terri Anne Powers, Vice President,
Investor Relations
312.889.5244 | tpowers@diplomat.is

MEDIA CONTACT:
Jenny Cretu, Senior Vice President,
Pharma Services and Marketing
810.768.9370 | jcretu@diplomat.is

View original content with multimedia:http://www.prnewswire.com/news-releases/diplomat-to-release-second-quarter-2018-operating-results-host-conference-call-on-aug-6-300680792.html

SOURCE Diplomat Pharmacy, Inc.